Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT) is characterized by abnormal blood vessel formation. One treatment for HHT-related arteriovenous malformations (AVMs) is sclerotherapy, which collapses the blood vessels by irritating the endothelial lining. Methods: This case series describes two HHT patients undergoing in-office sodium tetradecyl sulfate sclerotherapy for non-nasal telangiectasias and AVMs. The first patient had AVMs on the red lip while the second patient had an AVM and several telangiectasias on the tongue. Results: Both patients' AVMs required only one treatment visit and were no longer noticeable within a week. Neither of the patients had any side effects from treatment. Conclusion: Sclerotherapy was used to successfully treat HHT-related AVMs in-office with no scarring and is an option that should be considered by providers.
Original language | English |
---|---|
Article number | 104537 |
Journal | American Journal of Otolaryngology - Head and Neck Medicine and Surgery |
Volume | 46 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2025 |
Keywords
- Hereditary hemorrhagic telangiectasia
- Lip
- Sclerotherapy
- Tongue